Goldman Sachs Group »

Exagen shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Exagen (XGN) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Exagen

Tip: Access up to 7 years of quarterly data

All positions including Exagen held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exagen by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $679k 62k 10.99
2021-12-31 $125k 11k 11.64
2021-09-30 $145k 11k 13.64
2020-06-30 $2.4M 192k 12.41
2019-09-30 $279k 18k 15.50

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Spdr S&p 500 Etf Tr CMN (SPY)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Invesco Qqq Tr CMN Put Option (QQQ)
Tesla CMN (TSLA)
Amazon CMN (AMZN)
Meta Platforms CMN (META)
Alphabet CMN (GOOGL)
Broadcom CMN (AVGO)
Ishares Tr CMN (IVV)
Ishares Tr CMN Put Option (IWM)
Vanguard Index Fds CMN (VOO)
Ishares Tr CMN Put Option (HYG)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Exagen

Rtw Investments
Vanguard Group
Balyasny Asset Management
Invesco
Kennedy Capital Management
Morgan Stanley
Silvercrest Asset Management Group
Wexford Capital
Millennium Management
Two Sigma Investments
Russell Investments
FourWorld Capital Management
Susquehanna International
Manatuck Hill Partners
Geode Capital Management

View all funds holding Exagen